POSTER SESSION II
Monday, March 26, 2007   1:00 PM - 4:30 PM
Convention Center, Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
LIVER AND PANCREAS
Poster#
Title and Authors
Itinerary Planner
145
Pancreatic Ductal Carcinoma-Associated Changes May Histologically Simulate Autoimmune Pancreatitis
(1324)
K Notohara, M Kojima, S Ban, H Hamano, T Uehara, M Fujisawa, S Nose, K Omonishi, Y Wani, C Tsukayama, M Shimizu - Kurashiki Central Hospital, Kurashiki; National Cancer Center Hospital East, Kashiwa; Saitama Medical University School of Medicine, Saitama; Shinshu University School of Medicine, Matsumoto; Himeji Red Cross Hospital, Himeji; Okayama Saiseikai General Hospital, Okayama; Fukuyama City Hospital, Fukuyama, Japan
Clear Cell Carcinoma of the Pancreas: A Study of Its Pathologic Features and a Unique Biomarker-Hepatocyte Nuclear Factor-1 Beta
(1301)
L Kim, J Liao, M Zhang, M Talamonti, D Bentrem, S Rao, GY Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL
Reevaluation of Cancerization of the Duct by Pancreatic Cancers
(1267)
S Ban, Y Shimizu, F Ogawa, M Shimizu - Saitama Medical University School of Medicine, Moroyama, Iruma, Saitama, Japan
Gene Expression Profiling Identifies Calcium-Binding Proteins and Periostin among Genes Overexpressed in Pancreatic Adenocarcinoma
(1273)
SM Chung, RK Yantiss, H Tada, P Mukherjee, Y-T Chen - Weill Cornell Medical College, New York, NY; Temple University Hospital, Philadelphia, PA
Overexpression of Human Carcinoma-Associated Antigen in Pancreatic Adenocarcinoma
(1323)
P Nigwekar, TR Lester, Q Yang, PA Bourne, JL Yao, PA di Sant’Agnese, J Zhai, H Wang, J Huang - University of Rochester Medical Center, Rochester, NY; Methodist Hospital, Houston, TX; University of Texas MD Anderson Cancer Center, Houston, TX
Expression of S100A4, S100A6, and S100P in Pancreatic and Ampullary Adenocarcinomas
(1313)
F Lin, ME Hull, J Shi, JW Prichard, RE Brown, HL Wang, C Schuerch - Geisinger Medical Center, Danville, PA; Washington University School of Medicine, St. Louis, MO; University of Texas at Houston, Houston, TX
Adenylate Cyclase-Associated Protein 1 Overexpressed in Pancreatic Cancers Is Involved in Cancer Cell Motility
(1336)
M Sakamoto, K Yamazaki - Keio University School of Medicine, Tokyo, Japan
HLA Class I Antigen Processing Machinery Is Altered in Short-Term Survivors of Pancreatic Adenocarcinoma Compared to Long-Term Survivors
(1274)
SM Chung, CR Ferrone, S Ferrone, DS Klimstra - Weill Cornell Medical College, New York, NY; Massachusetts General Hospital, Boston, MA; Roswell Park Cancer Institute, Buffalo, NY; Memorial Sloan Kettering Cancer Center, New York, NY
Nucleolar Expression of Catalytic Subunit of Human Telomerase Reverse Transcriptase Is Associated with Better Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
(1312)
JJ Liang, A Rashid, T-T Wu, H Wang, KR Cleary, SR Hamilton, DB Evans, RF Hwang, HF Gomez, JL Abbruzzese, H Wang - The University of Texas M.D. Anderson Cancer, Houston; ; The University of Texas M.D. Anderson Cancer Center, Houston, TX
Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
(1311)
JJ Liang, H Wang, A Rashid, T-T Wu, KR Cleary, SR Hamilton, DB Evans, RF Hwang, HF Gomez, TH Tan, GS Zhou, JL Abbruzzese, H Wang - The University of Texas M.D. Anderson Cancer, Houston; Baylor College of Medicine, Houston, TX
FHIT Expression Is Decreased in Pancreatic Adenocarcinoma but Does Not Correlate with Survival
(1306)
JR Kneile, M Bloomston, WL Marsh, K Huebner, WL Frankel - Ohio State University, Columbus, OH
Overexpression of HMG-CoA Reductase, a Potential Therapeutic Target for Pancreatic Adenocarcinoma
(1302)
L Kim, J Liao, L Yan, M Zhang, S Rao, GY Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL
Mucus Extravasation in Pancreatic Intraepithelial Mucinous Neoplasms (IPMNs and MCNs): A Finding Not To Be Confused with Invasive Adenocarcinoma
(1341)
EB Stelow, TO Safo, SE Pambuccian, TW Bauer, JB Stokes, AM Bellizzi, RB Adams, CA Moskaluk - University of Virginia, Charlottesville, VA; University of Minnesota, Minneapolis, MN
Hep Par 1 Expression in Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas with and without Dysplasia and Invasive Carcinoma
(1335)
AF Safo, EB Stelow, J Jessurun, SE Pambuccian - University of Minnesota, Minneapolis, MN; University of Virginia, Charlottesville, VA
Serous Cystadenoma of the Pancreas as a Model of Clear-Cell Associated Angiogenesis and Tumorigenesis
(1348)
D Thirabanjasak, O Basturk, I Nalbantoglu, JD Cheng, E Levi, R Singh, NV Adsay - Wayne State Univ-Karmanos Cancer Inst, Detroit, MI; New York Univ, New York, NY; St.John Hospital and Medical Center, Detroit, MI
Differentiation of Serous Cystic Pancreatic Neoplasms and Metastatic Renal Cell Carcinoma by Immunohistochemistry
(1318)
CP Molina, M Kim, J Zhai, AG Ayala, JY Ro - The Methodist Hospital, Houston, TX; Asan Medical Center, Seoul, South Korea
β-Catenin and E-Cadherin Are the Most Sensitive and Specific Markers for Solid-Psuedopapillary Neoplasm of the Pancreas
(1303)
M-J Kim, S-J Jang, E Yu - University of Ulsan College of Medicine Asan Medical Center, Seoul, Republic of Korea
The Expression of E-Cadherin in Solid Pseudopapillary Tumors and Endocrine Tumors of the Pancreas
(1339)
S Serra, M Fageeh, F Niakosari, S Salahshor, JM Radhi, R Chetty - University Health Network, University of Toronto, Toronto, ON, Canada; University Health Network and University of Toronto, Toronto, ON, Canada; McMaster University, Hamilton, ON, Canada
Loss of Cell-Adhesion Molecule Complexes in Solid Pseudopapillary Tumor of Pancreas
(1342)
AA Stelter, S French, S Shen, S Qiu, HQ Wang, J Xie, R Venegas, WW Tang - University of Texas Medical Branch at Galveston, Galveston, TX; Harbor & UCLA Medical Center, Torrance, CA; Methodist Hospital, Houston, TX
Expression of Oct3/4, Nanog, CD34, CD56, ER and PR in Solid Pseudopapillary Neoplasms of the Pancreas; a Tissue Microarray Study of 50 Cases
(1276)
J Dancer, S Shen, J Jhai, M Kim, J Ro - Weil Medical College-The Methodist Hospital, Houston, TX; Asan Medical Center, Seoul, Republic of Korea
A Potential Pathogenic Mechanism of Pancreatic Endocrine Neoplasm Via p53 Ubiquitin-Protein Ligase MDM2
(1347)
LH Tang, P Allen, I Modica, J Shia, MF Brennan, DS Klimstra - Memorial Sloan-Kettering Cancer Center, New York, NY
Assessment of Prognosis of Pancreatic Endocrine Neoplasm by Correlation of Pathological Prognostic Factors with CK19 Immunoreactivity in 112 Cases
(1346)
LH Tang, P Allen, I Modica, C Ferrone, J Shia, MF Brennan, DS Klimstra - Memorial Sloan-Kettering Cancer Center, New York, NY
Islets, the King of Antigens? Non-Specific Reactivity of (Especially the) Islets Is a Common Pitfall in Immunohistochemical Evaluation of the Pancreas
(1321)
I Nalbantoglu, O Basturk, D Thirabanjasak, F Sarkar, JD Cheng, E Levi, NV Adsay - St.John Hosp and Medical Center, Detroit, MI; New York Univ, New York, NY; Wayne State Univ-Karmanos Cancer Inst, Detroit, MI
IgG4-Related Sclerosing Disease: Clinicopathological Correlations of 12 Cases of Retroperitoneal Fibrosis (RPF) without Autoimmune Pancreatitis
(1331)
M Rodriguez-Justo, GH Neild, JO Connolly, C Wall, P Munson - Royal Free & University College Medical School, London, United Kingdom; Royal Free Hospital, London, United Kingdom; Middlesex Hospital, London, United Kingdom
An IgG4+ to IgG+ Plasma Cells Ratio in Ampullary Tissue as a Marker To Differentiate Autoimmune Pancreatitis from Pancreatic Cancer
(1338)
A Sepehr, V Deshpande, GY Lauwers, M Mino-Kenudson - Massachusetts General Hospital, Boston, MA
CD24 Expression Predicts Poor Outcome in Cholangiocarcinoma
(1300)
T Khoury, S Argawal, J Yu, JF Gibbs, MG Brattain, MM Javle, B Kuvshinoff, Y Zakharia, DG Hicks - Roswell Park Cancer Institute, Buffalo, NY
Immunohistochemical Stains for FHIT, CDX2, p53, Maspin and Ki-67 Are Altered in Gallbladder Adenocarcinoma but Only Tumor Size Correlates with Survival
(1307)
JR Kneile, M Bloomston, M Butterfield, K Huebner, WL Frankel - Ohio State University, Columbus, OH